O-I Glass Stock Slides on BofA Double Downgrade Amid Market Sell-Off

Shares of O-I Glass (NYSE: OI) declined in pre-market trading after BofA Securities issued a rare double downgrade on the stock, citing growing uncertainty over the company's ability to meet its long-term financial goals.

Analyst Concerns Mount

BofA Securities slashed its rating on O-I Glass from "Buy" directly to "Underperform" and cut its price target to $11.00 from a previous $13.00. Analysts at the bank pointed to mounting skepticism about whether management can achieve its approximately $1.4 billion EBITDA objective for 2027.

According to the BofA note, while the stock had recently rebounded about 20%, the company's fundamental backdrop has deteriorated. This action follows other recent negative analyst revisions, including a price target cut by RBC Capital to $11 from $14, signaling a broader pessimistic shift in sentiment.

Fundamental and Market Headwinds

The downgrades reflect persistent investor concerns over the company's financial health. Key issues weighing on the stock include:

Ad

• A strained balance sheet with long-term debt near $4.8 billion and elevated leverage.
• A weak free cash flow outlook that provides little room for operational missteps.
• Disappointing first-quarter 2026 results, which showed a dramatically wider year-over-year net loss and an earnings per share figure that significantly missed estimates.

Exacerbating the company-specific issues was a broader market downturn. U.S. equities sold off after President Trump announced the reinstatement of a blockade on Iranian shipping, which caused a sharp spike in oil prices. As a capital-heavy manufacturer, O-I Glass is particularly sensitive to rising energy costs, creating an additional headwind for the stock.

Stock Performance

In pre-open trading, O-I Glass stock fell 3.0%. The combination of the high-conviction analyst downgrade, underlying financial weakness, and a geopolitically driven risk-off market environment extended the stock's prolonged underperformance, which has seen it trade far below its 52-week high of $16.91.